ContractPatent Assignment Agreement • May 5th, 2020 • Washington
Contract Type FiledMay 5th, 2020 JurisdictionEX-10.47 11 v52057a5exv10w47.htm EX-10.47 Exhibit 10.47 PATENT ASSIGNMENT AGREEMENT This agreement (the “Agreement”) is made effective the 23rd day of February 2009 (the “Effective Date”) between Omeros Corporation, a Washington corporation having a principal place of business at 1420 Fifth Avenue, Suite 2600, Seattle WA 98101 USA (“Omeros”) and Roberto Ciccocioppo, Ph.D., having a residence at Vicolo San Silvestro n. 25, Camerino, 62032 IT (“Dr. Ciccocioppo”). WHEREAS Dr. Ciccocioppo owns all rights to certain technology invented by Dr. Ciccocioppo related to new uses of peroxisome proliferator-activated receptor gamma (“PPARg”) agonists; and WHEREAS Omeros has provided services for and funded the expenses of filing patent applications for Dr. Ciccocioppo’ PPARg technology; and WHEREAS Omeros wishes to acquire all rights to Dr. Ciccocioppo’ PPARg technology and related patent applications and patents; and WHEREAS Dr. Ciccocioppo wishes to sell all rights to his PPARg technology to Ome
PATENT ASSIGNMENT AGREEMENTPatent Assignment Agreement • September 16th, 2009 • Omeros Corp • Pharmaceutical preparations • Washington
Contract Type FiledSeptember 16th, 2009 Company Industry JurisdictionThis agreement (the “Agreement”) is made effective the 23rd day of February 2009 (the “Effective Date”) between Omeros Corporation, a Washington corporation having a principal place of business at 1420 Fifth Avenue, Suite 2600, Seattle WA 98101 USA (“Omeros”) and Roberto Ciccocioppo, Ph.D., having a residence at Vicolo San Silvestro n. 25, Camerino, 62032 IT (“Dr. Ciccocioppo”).
PATENT ASSIGNMENT AGREEMENTPatent Assignment Agreement • May 15th, 2009 • Omeros Corp • Pharmaceutical preparations • Washington
Contract Type FiledMay 15th, 2009 Company Industry JurisdictionThis agreement (the “Agreement”) is made effective the 23rd day of February 2009 (the “Effective Date”) between Omeros Corporation, a Washington corporation having a principal place of business at 1420 Fifth Avenue, Suite 2600, Seattle WA 98101 USA (“Omeros”) and Roberto Ciccocioppo, Ph.D., having a residence at Vicolo San Silvestro n. 25, Camerino, 62032 IT (“Dr. Ciccocioppo”).